Febrile pleuropericarditis during valproic acid treatment
Tonnelier, J.M.; Mocquard, Y.; Broch, C.; Vandhuick, O.; Goas, P.; Goas, J.Y.
Presse Medicale 30(2): 62-63
2001
ISSN/ISBN: 0755-4982 PMID: 11244813 Document Number: 528559
Document emailed within 1 workday
Related Documents
Vajda, F.J. 1983: Valproic acid in the treatment of status epilepticus Advances in Neurology 34: 519-529Armijo, J.A.; Valiente, R.; Herranz, J.L. 1981: Relation between plasma levels of valproic acid alone and its efficacy and toxicity in pediatric patients under chronic treatment Archivos de Farmacologia y Toxicologia 7(1): 49-56
Porubek, D.J.; Grillo, M.P.; Baillie, T.A. 1989: The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(2): 123-130
Champel, V.; Radal, M.; Moulin-Vallez, M.; Jonville-Béra, A.P.; Autret-Leca, E. 1999: Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy Revue Neurologique (Paris) 155(3): 220-224
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Kohda, Y. 1995: Valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 918-920
Borchert, H.H.; Schuster, S.; Pfeifer, S. 1980: Metabolic interaction of valproic acid Die Pharmazie 34(5-6): 313-314
Gedan, A.; Kleemann, V.; Pfeifer, S. 1984: Hydrolysis of valproamide to valproic acid Die Pharmazie 39(12): 865
Klotz, U. 1977: Pharmacokinetic studies with valproic acid in man Arzneimittel-Forschung 27(5): 1085-1088
Waring, E.W.; Dewan, V.K.; Cohen, D.; Grewal, R. 1999: Risperidone as an adjunct to valproic acid Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(2): 189
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
Kohda, Y. 1990: Therapeutic drug monitoring of valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1130-1133
Bruni, J.; Wilder, B.J.; Willmore, L.J.; Barbour, B. 1979: Valproic acid and plasma levels of phenytoin Neurology 29(6): 904-905
Michaelis, M.; Doerr, H.W.; Cinatl, J. 2007: Valproic acid as anti-cancer drug Current Pharmaceutical Design 13(33): 3378-3393
Löscher, W. 1981: Anticonvulsant activity of metabolites of valproic acid Archives Internationales de Pharmacodynamie et de Therapie 249(1): 158-163
Van Woert, M.H.; Chung, E.Y. 1986: Possible mechanisms of action of valproic acid in myoclonus Advances in Neurology 43: 653-660
Blicher, T.M.; Vestergaard, E.T.; Dalhoff, K.P. 2012: The clinical course of a three year-old girl after overdose of valproic acid Ugeskrift for Laeger 174(17): 1165-1166
Rodat, O.; Nicolas, G.; Anger, J.P.; Develay-Legueut, M.A.; Michaux, P. 1985: Sudden death in epileptics treated with valproic acid Acta Medicinae Legalis et Socialis 35(1): 123-134
Sorel, L.; Rucquoy-Ponsar, M.; Willems, C.; Diepart, E.; Harmant, J. 1981: Comparative study of valproic acid and sodium valproate Acta Neurologica Belgica 81(5): 283-290
Garden, A.S.; Benzie, R.J.; Hutton, E.M.; Gare, D.J. 1985: Valproic acid therapy and neural tube defects Canadian Medical Association Journal 132(8): 933; 936